Authors:
Suryapranata, H
Ottervanger, JP
Nibbering, E
van't Hof, AW
Hoorntje, JCA
de Boer, MJ
Al, MJ
Zijlstra, F
Citation: H. Suryapranata et al., Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction, HEART, 85(6), 2001, pp. 667-671
Authors:
Ottervanger, JP
van't Hof, AWJ
Reiffers, S
Hoorntje, JCA
Suryapranata, H
de Boer, MJ
Zijlstra, F
Citation: Jp. Ottervanger et al., Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction, EUR HEART J, 22(9), 2001, pp. 785-790
Authors:
Liem, A
Zijlstra, F
Ottervanger, JP
Hoorntje, JCA
Suryapranata, H
de Boer, MJ
Verheugt, FWA
Citation: A. Liem et al., High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The Heparin in Early Patency (HEAP) randomized trial, J AM COL C, 35(3), 2000, pp. 600-604
Authors:
Thomas, K
Ottervanger, JP
de Boer, MJ
Suryapranata, H
Hoorntje, JCA
Zijlstra, F
Citation: K. Thomas et al., Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients, DIABET CARE, 22(4), 1999, pp. 647-649
Authors:
Zijlstra, F
Hoorntje, JCA
de Boer, MJ
Reiffers, S
Miedema, K
Ottervanger, JP
van't Hof, AWJ
Suryapranata, H
Citation: F. Zijlstra et al., Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction, N ENG J MED, 341(19), 1999, pp. 1413-1419
Authors:
Ottervanger, JP
Liem, A
de Boer, MJ
van't Hof, AWJ
Suryapranata, H
Hoorntje, JCA
Zijlstra, F
Citation: Jp. Ottervanger et al., Limitation of myocardial infarct size after primary angioplasty: Is a higher potency the only mechanism?, AM HEART J, 137(6), 1999, pp. 1169-1172